Stevens R, Scheuerer S, Schuelert N, Corradini L. Evaluation of the Selective Oral CCR2 Antagonist CNTX-6970 in the Treatment of Osteoarthritis Pain; Results from Preclinical Studies of Pharmacokinetics and Efficacy [abstract]. Presented at: PAINWeek 2019, Las Vegas, Nevada, September 3-7, 2019.